273 related articles for article (PubMed ID: 29157215)
1. Integration of RNA-Seq data with heterogeneous microarray data for breast cancer profiling.
Castillo D; Gálvez JM; Herrera LJ; Román BS; Rojas F; Rojas I
BMC Bioinformatics; 2017 Nov; 18(1):506. PubMed ID: 29157215
[TBL] [Abstract][Full Text] [Related]
2. Multiclass classification for skin cancer profiling based on the integration of heterogeneous gene expression series.
Gálvez JM; Castillo D; Herrera LJ; San Román B; Valenzuela O; Ortuño FM; Rojas I
PLoS One; 2018; 13(5):e0196836. PubMed ID: 29750795
[TBL] [Abstract][Full Text] [Related]
3. RNA-Seq vs dual- and single-channel microarray data: sensitivity analysis for differential expression and clustering.
Sîrbu A; Kerr G; Crane M; Ruskin HJ
PLoS One; 2012; 7(12):e50986. PubMed ID: 23251411
[TBL] [Abstract][Full Text] [Related]
4. Using microarray-based subtyping methods for breast cancer in the era of high-throughput RNA sequencing.
Pedersen CB; Nielsen FC; Rossing M; Olsen LR
Mol Oncol; 2018 Dec; 12(12):2136-2146. PubMed ID: 30289602
[TBL] [Abstract][Full Text] [Related]
5. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
6. Parallel comparison of Illumina RNA-Seq and Affymetrix microarray platforms on transcriptomic profiles generated from 5-aza-deoxy-cytidine treated HT-29 colon cancer cells and simulated datasets.
Xu X; Zhang Y; Williams J; Antoniou E; McCombie WR; Wu S; Zhu W; Davidson NO; Denoya P; Li E
BMC Bioinformatics; 2013; 14 Suppl 9(Suppl 9):S1. PubMed ID: 23902433
[TBL] [Abstract][Full Text] [Related]
7. Improving reliability and absolute quantification of human brain microarray data by filtering and scaling probes using RNA-Seq.
Miller JA; Menon V; Goldy J; Kaykas A; Lee CK; Smith KA; Shen EH; Phillips JW; Lein ES; Hawrylycz MJ
BMC Genomics; 2014 Feb; 15(1):154. PubMed ID: 24564186
[TBL] [Abstract][Full Text] [Related]
8. Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes.
Warnat P; Eils R; Brors B
BMC Bioinformatics; 2005 Nov; 6():265. PubMed ID: 16271137
[TBL] [Abstract][Full Text] [Related]
9. Feature specific quantile normalization enables cross-platform classification of molecular subtypes using gene expression data.
Franks JM; Cai G; Whitfield ML
Bioinformatics; 2018 Jun; 34(11):1868-1874. PubMed ID: 29360996
[TBL] [Abstract][Full Text] [Related]
10. Classification across gene expression microarray studies.
Buness A; Ruschhaupt M; Kuner R; Tresch A
BMC Bioinformatics; 2009 Dec; 10():453. PubMed ID: 20042109
[TBL] [Abstract][Full Text] [Related]
11. A probabilistic approach for automated discovery of perturbed genes using expression data from microarray or RNA-Seq.
Sundaramurthy G; Eghbalnia HR
Comput Biol Med; 2015 Dec; 67():29-40. PubMed ID: 26492320
[TBL] [Abstract][Full Text] [Related]
12. A unified framework for finding differentially expressed genes from microarray experiments.
Shaik JS; Yeasin M
BMC Bioinformatics; 2007 Sep; 8():347. PubMed ID: 17877806
[TBL] [Abstract][Full Text] [Related]
13. Leukemia multiclass assessment and classification from Microarray and RNA-seq technologies integration at gene expression level.
Castillo D; Galvez JM; Herrera LJ; Rojas F; Valenzuela O; Caba O; Prados J; Rojas I
PLoS One; 2019; 14(2):e0212127. PubMed ID: 30753220
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive sensitivity analysis of microarray breast cancer classification under feature variability.
Sontrop HM; Moerland PD; van den Ham R; Reinders MJ; Verhaegh WF
BMC Bioinformatics; 2009 Nov; 10():389. PubMed ID: 19941644
[TBL] [Abstract][Full Text] [Related]
15. Probe Region Expression Estimation for RNA-Seq Data for Improved Microarray Comparability.
Uziela K; Honkela A
PLoS One; 2015; 10(5):e0126545. PubMed ID: 25966034
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the microarray gene expression for breast cancer progression after the application modified logistic regression.
Morais-Rodrigues F; Silv Erio-Machado R; Kato RB; Rodrigues DLN; Valdez-Baez J; Fonseca V; San EJ; Gomes LGR; Dos Santos RG; Vinicius Canário Viana M; da Cruz Ferraz Dutra J; Teixeira Dornelles Parise M; Parise D; Campos FF; de Souza SJ; Ortega JM; Barh D; Ghosh P; Azevedo VAC; Dos Santos MA
Gene; 2020 Feb; 726():144168. PubMed ID: 31759986
[TBL] [Abstract][Full Text] [Related]
17. Robust multi-tissue gene panel for cancer detection.
Irgon J; Huang CC; Zhang Y; Talantov D; Bhanot G; Szalma S
BMC Cancer; 2010 Jun; 10():319. PubMed ID: 20569444
[TBL] [Abstract][Full Text] [Related]
18. Feature selection and classification of MAQC-II breast cancer and multiple myeloma microarray gene expression data.
Liu Q; Sung AH; Chen Z; Liu J; Huang X; Deng Y
PLoS One; 2009 Dec; 4(12):e8250. PubMed ID: 20011240
[TBL] [Abstract][Full Text] [Related]
19. Comparing next-generation sequencing and microarray technologies in a toxicological study of the effects of aristolochic acid on rat kidneys.
Su Z; Li Z; Chen T; Li QZ; Fang H; Ding D; Ge W; Ning B; Hong H; Perkins RG; Tong W; Shi L
Chem Res Toxicol; 2011 Sep; 24(9):1486-93. PubMed ID: 21834575
[TBL] [Abstract][Full Text] [Related]
20. On the statistical assessment of classifiers using DNA microarray data.
Ancona N; Maglietta R; Piepoli A; D'Addabbo A; Cotugno R; Savino M; Liuni S; Carella M; Pesole G; Perri F
BMC Bioinformatics; 2006 Aug; 7():387. PubMed ID: 16919171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
